Heather Hill Selected Research

Heather Hill Research Topics

28	Human Influenza (Influenza) 01/2022 - 03/2008
7	Vaccinia 10/2021 - 12/2007
7	Influenza in Birds (Avian Flu) 01/2017 - 03/2008
3	Infections 01/2022 - 01/2015
3	Tularemia 12/2019 - 01/2017
2	Coccidioidomycosis 01/2015 - 03/2013
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Rheumatoid Arthritis 01/2020
1	Fever (Fevers) 01/2019
1	Tetanus 01/2019
1	Disease Progression 01/2019
1	Inflammation (Inflammations) 06/2017
1	Headache (Headaches) 01/2017
1	Dementia (Dementias) 03/2015
1	Anthrax 10/2014
1	Gastroenteritis 04/2014
1	Pain (Aches) 11/2009
1	Smallpox (Variola) 12/2007

34	VaccinesIBA 01/2022 - 12/2007
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 07/2015
5	MF59 oil emulsionIBA 01/2021 - 03/2008
4	Aluminum Hydroxide (Algeldrate)FDA Link 11/2009 - 03/2008
3	AntigensIBA 10/2021 - 03/2011
3	Hemagglutinins (Hemagglutinin)IBA 12/2014 - 11/2008
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 10/2021 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2017
2	AntibodiesIBA 10/2021 - 02/2020
2	CytokinesIBA 02/2020 - 12/2019
2	MVA vaccineIBA 02/2020 - 01/2017
2	AS03 adjuvantIBA 01/2016 - 12/2014
2	Inactivated VaccinesIBA 08/2015 - 12/2014
2	Neutralizing AntibodiesIBA 05/2014 - 11/2009
2	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 06/2013 - 12/2007
1	Attenuated VaccinesIBA 01/2021
1	EnzymesIBA 02/2020
1	ImmunosorbentsIBA 02/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	2-(2,4-dimethylphenyl)indan-1,3-dioneIBA 01/2020
1	Viral VaccinesIBA 12/2019
1	Biological Warfare AgentsIBA 12/2019
1	InterferonsIBA 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2019
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2019
1	AerosolsIBA 01/2017
1	SoilIBA 01/2015
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 10/2014
1	Blood Group Antigens (Blood Groups)IBA 04/2014
1	Subunit VaccinesIBA 03/2011
1	hydroxide ionIBA 11/2009
1	Antiviral Agents (Antivirals)IBA 04/2009